Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L Ala-Kokko is active.

Publication


Featured researches published by L Ala-Kokko.


European Journal of Human Genetics | 1998

First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q

Marcella Devoto; K. Shimoya; John Caminis; Jurg Ott; Alan Tenenhouse; Mp Whyte; Larisa Sereda; S Hall; Eileen L. Considine; Charlene J. Williams; G. Tromp; Helena Kuivaniemi; L Ala-Kokko; Darwin J. Prockop; Loretta D. Spotila

Osteoporosis is characterized by low bone density, and osteopenia is responsible for 1.5 million fractures in the United States annually.1 In order to identify regions of the genome which are likely to contain genes predisposing to osteopenia, we genotyped 149 members of seven large pedigrees having recurrence of low bone mineral density (BMD) with 330 DNA markers spread throughout the autosomal genome. Linkage analysis for this quantitative trait was carried out using spine and hip BMD values by the classical lod-score method using a genetic model with parameters estimated from the seven families. In addition, non-parametric analysis was performed using the traditional Haseman-Elston approach in 74 independent sib pairs from the same pedigrees. The maximum lod score obtained by parametric analysis in all families combined was +2.08 (θ = 0.05) for the marker CD3D on chromosome 11q. All other combined lod scores from the parametric analysis were less than +1.90, the threshold for suggestive linkage. Non-parametric analysis suggested linkage of low BMD to chromosomes 1p36 (Zmax = +3.51 for D1S450) and 2p23-24 (Zmax = +2.07 for D2S149). Maximum multi-point lod scores for these regions were +2.29 and +2.25, respectively. A third region with associated lod scores above the threshold of suggestive linkage in both single-point and multi-point non-parametric analysis was on chromosome 4qter (Zmax = +2.95 for D4S1539 and Zmax = +2.48 for D4S1554). Our data suggest the existence of multiple genes involved in controlling spine and hip BMD, and indicate several candidate regions for further screening in this and other independent samples.


Immunology | 1998

Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice.

Linda K. Myers; David D. Brand; X J Ye; M A Cremer; Edward F. Rosloniec; Michael Bodo; Johanna Myllyharju; T Helaakoski; Minna Nokelainen; Taina Pihlajaniemi; Kari I. Kivirikko; C L Yang; L Ala-Kokko; Darwin J. Prockop; H Notbohm; Peter P. Fietzek; J.M. Stuart; A.H. Kang

Recombinant human type II collagen (rhCII) was produced using both the HT1080 mammalian cell expression system (rhCIIht) and a baculovirus expression system (rhCIIbac). The biosynthesis of CII requires extensive post‐translational modifications, such as the hydroxylation of prolyl and lysyl residues and glycosylation of hydroxylysyl residues. Amino acid analyses indicated that the rhCIIbac was adequately hydroxylated at prolyl residues but underhydroxylated at lysyl residues and underglycosylated compared with tissue‐derived hCII, while rhCIIht was hyperhydroxylated and hyperglycosylated at lysyl residues. When the murine collagen‐induced arthritis (CIA) model was used to investigate the immunological properties of the two forms of recombinant CII, each induced a high incidence of arthritis following immunization of susceptible mice when emulsified with complete Freund’s adjuvant (CFA). However, the severity of the arthritis, as assessed by the number of affected limbs, was significantly higher in mice immunized with rhCIIht than in mice immunized with rhCIIbac. These data indicate that the degree of hydroxylysine glycosylation may play a role in the induction of the arthritogenic response to CII. Each of the recombinant collagens was comparable to tissue‐derived hCII in their ability to induce tolerance and suppress arthritis when given as intravenous or oral tolerogens. Taken together, our data suggest that recombinant CII can be prepared in adequate amounts for therapeutic uses and that the material is immunologically comparable to tissue‐derived hCII when used to induce tolerance.


Molecular Psychiatry | 2000

Sequence and genomic organization of the human G-protein Golfα gene ( GNAL ) on chromosome 18p11, a susceptibility region for bipolar disorder and schizophrenia

Jussi T. Vuoristo; W H Berrettini; Joan Overhauser; Darwin J. Prockop; T N Ferraro; L Ala-Kokko

The sequence and genomic organization of the human Golfα (GNAL) gene were determined. The human GNAL gene was found to contain 12 coding exons, and it spans over 80 kb on chromosome 18p11. 5′ RACE analysis suggested an additional transcription initiation start site. Sequence analysis of the putative promoter region revealed conserved binding sites for several transcription factors. Sequence analysis of the 3′-untranslated region revealed the presence of two Alu sequences and two polyadenylation signals. 3′ RACE analysis confirmed the functionality of the most downstream poly-a signal. The human GNAL was found to be expressed as a single transcript of about 5.9 kb in the brain. One highly informative dinucleotide repeat was found in intron 5. Additionally, a processed pseudogene for asparagine synthetase was found about 6 kb upstream of the GNAL gene. Knowledge of the sequence and structure of the human GNAL gene provides essential information for further analysis of the GNAL locus at chromosome 18p11 which has been linked to bipolar disorder and schizophrenia.


Matrix | 1990

Efficient Procedure for Preparing Cosmid Libraries from Microgram Quantities of Genomic DNA Fragments Size Fractionated by Gel Electrophoresis

L Ala-Kokko; Darwin J. Prockop

A modified procedure for preparing cosmid libraries from genomic DNA is described. Genomic DNA was partially digested with a restriction endonuclease, and DNA fragments of appropriate size fractionated by agarose gel electrophoresis. A cosmid library was prepared, prescreened, and used to isolate gene inserts with previously published procedures. In one series of experiments, a modified cosmid vector containing stuffer fragments was used to prepare cosmid libraries containing partial SphI digests of 25 to 35 kb. From 10(5) to 10(7) clones were obtained per microgram of size-fractionated genomic DNA. From 10 to 100 hybridization-positive clones of a single copy gene (COL2A1) were obtained from plates that were positive in the prescreening step. Restriction mapping of over 20 clones and nucleotide sequencing of over 20,000 bp in each of two clones indicated that the inserts were faithful copies of the gene. In another experiment, a standard cosmid vector was used to prepare a cosmid library containing partial BamHI fragments of 30 to 45 kb. Genomic libraries can be prepared with 5 to 20 micrograms of genomic DNA and a large number of clones containing 25 to 45 kb fragments of a single copy gene can be isolated in about three weeks.


Proceedings of the National Academy of Sciences of the United States of America | 1990

Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia

L Ala-Kokko; Clinton T. Baldwin; Roland W. Moskowitz; Darwin J. Prockop


Proceedings of the National Academy of Sciences of the United States of America | 1991

Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy).

N. Nina Ahmad; L Ala-Kokko; Robert G. Knowlton; Sergio A. Jimenez; Eric J. Weaver; J I Maguire; W Tasman; Darwin J. Prockop


Biochemical Journal | 1989

Structure of cDNA clones coding for the entire preproα1(III) chain of human type III procollagen: differences in protein structure from type I procollagen and conservation of codon preferences

L Ala-Kokko; Sirpa Kontusaari; Clinton T. Baldwin; Helena Kuivaniemi; Darwin J. Prockop


Annals of the Rheumatic Diseases | 2003

Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis

Noora Noponen-Hietala; E Kyllönen; Minna Männikkö; E Ilkko; Jaro Karppinen; Jurg Ott; L Ala-Kokko


Proceedings of the National Academy of Sciences of the United States of America | 1991

Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia

Philipp Vandenberg; Jaspal S. Khillan; Darwin J. Prockop; Heikki J. Helminen; Sirpa Kontusaari; L Ala-Kokko


Archive | 1992

Synthesis of human procollagens and collagens in recombinant DNA systems

Darwin J. Prockop; L Ala-Kokko; Andrzej Fertala; Aleksander L. Sieron; Kari I. Kivirikko; Amy Geddis

Collaboration


Dive into the L Ala-Kokko's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrzej Fertala

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amy Geddis

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sirpa Kontusaari

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge